EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Neurobiological and Molecular Mechanisms of Cannabidiol in Depressive Disorders: A Preclinical Systematic Review

Graziele Larissa Fontes Alves, Desyree de Farias Gonçalves, Paulo Cezar de Oliveira, Danilo de Queiroz Tavares, Gustavo Carrião, Carlos Rocha Oliveira

Pará Research Medical Journal · 07.08.2026 · 10

DOI: 10.5327/prmj.944 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pará Research Medical Journal, online erschienen am 07.08.2026. Verfasst von Graziele Larissa Fontes Alves und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This review aims evaluated preclinical studies published in the last five years investi gating the antidepressant-like effects of CBD and related cannabinoids.

Methods

This work is a systematic review. The entire process of selecting and choosing the studies for the review was carried out according to the PRISMA protocol. The descriptors used were "Depressive Disorder", "Cannabidiol", and "Phytotherapy". Seven experimental studies met the inclusion criteria.

Results

The reviewed evidence demonstrates that CBD reduces immobility in the forced swim test, increases sucrose preference, and modulates molecular pathways associated with neuroplasticity and inflammation. Key mechanisms include activation of AMPA receptors, modulation of serotonergic and noradrenergic transmission, reduction of NF-κB and IL-6 expression, and regulation of the kynurenine pathway. Additionally, CBD influences hippocampal neurogenesis and exhibits anti-inflammatory and anti-apoptotic effects through BDNF/TRPC6 signaling.

Conclusion

Collectively, these findings highlight the multifactorial antidepressant potential of CBD and its analogs, suggesting a role as adjunctive or alternative therapies for mood disorders. However, further randomized controlled trials in humans are essential to confirm efficacy, safety, and optimal dosing parameters for clinical use.

Zitieren

APA

Alves, G. L. F., Gonçalves, D. D. F., Oliveira, P. C. D., Tavares, D. D. Q., Carrião, G., & Oliveira, C. R. (2026). Neurobiological and Molecular Mechanisms of Cannabidiol in Depressive Disorders: A Preclinical Systematic Review. Pará Research Medical Journal, 10. https://doi.org/10.5327/prmj.944

Vancouver

Alves GLF, Gonçalves DDF, Oliveira PCD, Tavares DDQ, Carrião G, Oliveira CR. Neurobiological and Molecular Mechanisms of Cannabidiol in Depressive Disorders: A Preclinical Systematic Review. Pará Research Medical Journal. 2026;10. doi:10.5327/prmj.944

BibTeX
@article{Alves2026,
  author = {Alves, Graziele Larissa Fontes and Gonçalves, Desyree de Farias and Oliveira, Paulo Cezar de and Tavares, Danilo de Queiroz and Carrião, Gustavo and Oliveira, Carlos Rocha},
  title = {Neurobiological and Molecular Mechanisms of Cannabidiol in Depressive Disorders: A Preclinical Systematic Review},
  journal = {Pará Research Medical Journal},
  year = {2026},
  volume = {10},
  doi = {10.5327/prmj.944}
}
Kostenlos starten →